PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children'... (cts via office coffee services food serv...)

PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital

Date:3/18/2008

cts via office coffee services, food service distributors, and thousands of leading supermarkets in the United States. Tully's corporate headquarters and roasting plant are located at 3100 Airport Way S. in Seattle, Wash. For more information: (800) 96-Tully or http://www.tullys.com.

About Children's Hospital and Regional Medical Center

Consistently ranked as one of the best children's hospitals in the country by U.S. News & World Report, Children's serves as the pediatric referral center for Washington, Alaska, Montana and Idaho. Children's has been delivering superior patient care for 100 years, including advancing new discoveries and treatments in pediatric research, and serving as a primary teaching, clinical and research site for the Department of Pediatrics at the University of Washington School of Medicine.

CONTACTS:

Jon Osterberg (206) 628-4019 Mark Firmani (206) 443-9357

PEMCO Insurance Firmani + Associates Inc.

jon.osterberg@pemco.com mark@firmani.com

SOURCE PEMCO Insurance
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine news :

1. TAX ALERT: Deductions for Long Term Care Insurance Premiums
2. New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders
3. Enabling the Mobile Workforce ... Entrust Deploys Strong Authentication for German Health Insurance Expert
4. AARP Services Inc. and Genworth Financial Introduce New Innovative and Affordable Long Term Care Insurance Option to AARP Members
5. InsureMyTravelVisa.com: Providing Embassy Required Travel Medical Insurance for Travel Visas
6. Seven Corners Alerts Spring Breakers that They Need Travel Insurance to Vacation Abroad
7. Darwin Introduces New Managed Care Corporate Liability Insurance
8. Health Secretary Calls for Action on Health Insurance for All Pennsylvanians During Visit to Alma Illery Center in Pittsburgh
9. Accident Fund Honors Serpe Insurance Agency with its Presidents Club Award
10. Accident Fund Honors Crissie Insurance Group with Its Presidents Club Award
11. Pennsylvania Health Secretary Visits Westmoreland County to Urge Passage of Health Insurance for All Pennsylvanians

Post Your Comments:

(Date:12/6/2009)... Dec. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... from the pivotal Phase 2b 003-A1 study, known ... well-tolerated in heavily pre-treated relapsed and refractory multiple ... the ASH/ASCO Joint Symposium at the 51st annual ... in New Orleans. Enrollment in this trial is ...

(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...

(Date:12/6/2009)... says dangerous substances such as asbestos have been found in toys ... ... (PRWEB) December 6, 2009 -- As parents shop for children,s toys ... recalls due to lead paint or asbestos contamination, says a New ... emergency rooms each year due to toy-related injuries,” says Joseph W. ...

(Date:12/5/2009)... What: Cuts for a Cause ,, Why: ... and other terminal illnesses affecting children. All proceeds from each ... Research Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, ... in Falls Church for all guests. Hoa Lai, a DJ ...

(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...

[1] Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability [0] New drug shows promise for those with clotting disorders: McMaster researcher [0] Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season [0] Salon Leau to Host 'Cuts for a Cause' to Raise Funds and Spread the Word About Childhood Terminal Illnesses [0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders

... Physicians with Flexibility and Control for Lead ... ... SPNC ) today announced the availability of the new LLD,EZ Lead ... leads. The LLD EZ enables physicians to secure,the entire lead creating traction ...

... WELLINGTON, Fla., May 15 The Quantum Group,Inc. ... announced today,through its subsidiary, Renaissance Health Systems, Inc. ... to centralize information pertaining,to the top five (5) ... and secure,HIPAA compliant environment. In addition to providing ...

... grant program will fund a pilot study in Vietnam ... for getting type 2 diabetes and promote a program ... , The National Hospital of Endocrinology (NHOE) will launch ... questionnaires (1) , the investigators hope to identify people ...

... Inc., the developer,of the first and only flexible ... surgery, today announced the closing of a $25 ... healthcare venture capital,and private equity firm, led the ... Stata Venture Partners, 3i, Argonaut,Ventures, ESI, Gainesborough Investments, ...

... Enables Creation of Global Unified Worklist ... or System, SEATTLE, May 15 Compressus, ... Seattle Radiologists, APC, of,Seattle, announced today an agreement ... imaging and data management systems.,The implementation, which will ...

... wealth of healthcare and medical device experience to board ... of ... developer,of the first and only flexible CO2 laser scalpel enabling new ... been,elected to the company,s board of directors. Suennen, co-founder and,managing member ...

Other Medicine News:Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 2 Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 3 Health News:The Quantum Group Announces Web-Based Portal for Physicians 2 Health News:The Quantum Group Announces Web-Based Portal for Physicians 3 Health News:International Diabetes Federation gives grant to diabetes screening & prevention program in Vietnam 2 Health News:OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration 2 Health News:OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration 3 Health News:Compressus Announces Seattle Radiologists Interoperability Implementation 2 Health News:Compressus Announces Seattle Radiologists Interoperability Implementation 3 Health News:Lisa M. Suennen Joins OmniGuide(R) Board of Directors 2

Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads The Quantum Group Announces Web-Based Portal for Physicians International Diabetes Federation gives grant to diabetes screening & prevention program in Vietnam OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration Compressus Announces Seattle Radiologists Interoperability Implementation Lisa M. Suennen Joins OmniGuide(R) Board of Directors

(Date:12/4/2009)... (NYSE: WPI ), a leading global specialty ... Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with ... market its 8mg ramelteon tablets prior to the expiration ... Watson,s 8mg ramelteon tablet product is a generic ...

(Date:12/4/2009)... disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), ... comorbidities reported to occur more often in people ... versus those without an epilepsy diagnosis, according to ... U.S. ,, Findings from " CNS-Related Comorbidities in ...

(Date:12/3/2009)... (Nasdaq: PCYC ), a biopharmaceutical company focused on ... treatment of immune mediated diseases and cancer, today announced ... on, Tuesday, December 8, 2009 at 11:00am Eastern Time ... clinical data regarding its HDAC Program (PCI-24781) and its ...

Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2 Watson Files FDA Application for Generic Rozerem(R) 3 Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2 Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3 Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 1 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 2 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 3 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 4 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 5 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 6 Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 7 Young Ballerinas May Face Heart Bone Risks 47452 1 Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 1 Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 2 Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 3

[0] Watson Files FDA Application for Generic Rozerem(R)[0] Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment [0] Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7

... Jan. 7 ImQuest Life Sciences announced today the ... and Drug Administration to initiate human clinical trials for ... their Phase 1 studies in the first quarter of ... HIV which primarily acts as a nonnucleoside reverse transcriptase ...

... U.S., U.K. and China TrialsSAN DIEGO, Jan. 7 ... liver disease, today announced patient enrollment has begun for ... will study the Extracorporeal Liver Assist Device (ELAD) as ... under three protocols. The study is open for enrollment ...

Other Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3

ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers

ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....

ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....

Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...

Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...

Medicine Products:

ISI Alumi-Hand ISI DuraHand Bio-Adembeads Magnetic Beads Conjugated To Streptavidin Streptavidin A-Beads

PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children'...(cts via office coffee services food serv...),Health